Antacids Market Is Expected to Reach $9.1 Billion by 2032: Allied Market Research

The growth of the antacids market is attributed to several factors, including the rise in the prevalence of gastroesophageal reflux disease (GERD), the easy availability of over the counter (OTC) antacids, and an increase in antacid demand among the geriatric population. By distribution channel, the drug stores and retail pharmacies segment held the highest share in 2022. By region, North America accounted for a major antacids market share in 2022 and is expected to maintain its dominance during the forecast period.


Portland, OR, May 02, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global antacids market generated $6.7 billion in 2022 and is estimated to reach $9.1 billion by 2032, witnessing a CAGR of 3.1% from 2023 to 2032. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chains, regional landscape, and competitive scenario. The report is a helpful source of information for leading market players, new entrants, investors, and stakeholders in devising strategies for the future and taking steps to strengthen their position in the market. 

Request Sample Report- https://www.alliedmarketresearch.com/request-sample/10646

Report coverage & details: 

Report Coverage  Details 
 

Forecast Period 
2023-2032 
 

Base Year 
2022 
 

Market Size in 2022 
$6.7 Billion  
 

Market Size in 2032 
$9.1 Billion  
 

CAGR 
3.1% 
 

No. of Pages in Report 
249 
 

Segments Covered 
Mechanism of Action, Formulation Type, Distribution Channel, and Region 
 

Drivers 
Rise in the prevalence of gastroesophageal reflux disease (GERD) 
Easy availability of over the counter (OTC) antacids 
The surge in demand for antacids among the geriatric population 
 

Opportunities 

 
 

Rapid changes in global population lifestyle 
 

Restraints 
Restrictions on the use of antacids 
The emergence of newer and more effective alternative treatments for acid-related conditions 

Impact of COVID-19 on Antacids Market: 

  • The COVID-19 pandemic had a mixed effect on the antacid industry. The prevalence of gastrointestinal symptoms, including heartburn and acid reflux, increased significantly during the pandemic, leading to a surge in demand for antacids. However, disruptions in supply chains and distribution systems due to lockdowns and trade restrictions caused delays and shortages in some areas, affecting the availability of antacids. 
  • Despite the challenges faced during the pandemic, several nations implemented strategies to stabilize the supply chain for medicines and medical equipment, including antacids. As the world is gradually recovering from the pandemic, the antacid market has seen rapid growth in recent times. 

Procure Complete Report (249 Pages PDF with Insights, Charts, Tables, and Figures)
https://www.alliedmarketresearch.com/checkout-final/antacids-market

The report comprehensively analyzes the global antacids market covering its various segments such as the mechanism of action, formulation type, distribution channel, and region. The report provides an analysis of each segment and sub-segment with the help of tables and figures. This analysis helps market players, investors, and new entrants in determining the sub-segments to be tapped into to achieve growth in the coming years.  

By mechanism of action, the non-systemic antacids segment held the major share in 2022, garnering more than three-fifths of the global antacids market revenue, and is projected to maintain its dominance by 2032. The same segment, on the other hand, would also showcase the fastest CAGR of 3.4% during the forecast period. The systemic antacids segment is also studied in the report.  

By formulation type, the tablets segment held the largest share in 2022, contributing to nearly half of the global antacids market revenue, and is projected to rule the roost by 2032. Furthermore, the liquids segment would display the fastest CAGR of 3.6% during the forecast period. The others segment is also analyzed in the report.  

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/10646

By distribution channel, the drug stores and retail pharmacies segment held the largest share in 2022, accounting for more than three-fifths of the global antacids market revenue, and is expected to lead the trail from 2023 to 2032. However, the online providers segment is likely to achieve the fastest CAGR of 5.0% by 2032. The hospital pharmacies segment is also discussed in the report.  

By region, the market in North America was the largest in 2022, garnering around two-fifths of the global antacids market revenue. However, the market in Asia-Pacific is expected to manifest the fastest CAGR of 3.9% throughout the forecast period. The other provinces studied in the report include Europe and LAMEA.  

The key players of the global antacids market analyzed in the research include WellSpring Pharmaceutical Corporation, Bayer AG, Cipla Ltd, Pfizer Inc., Alkem Laboratories Ltd., Abbott Laboratories, Reckitt Benckiser Group PLC, In first Healthcare Inc., Haleon plc, and Prestige Consumer Healthcare Inc. These players have adopted various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry.   

Trending Reports in Healthcare Industry-

Syphilis Testing Market - Global Opportunity Analysis and Industry Forecast, 2020-2030

Capsule Endoscopy System Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Micromanipulators Market- Global Opportunity Analysis and Industry Forecast, 2020–2030

Flow Cytometry Market- Global Opportunity Analysis and Industry Forecast, 2020–2030

Postpartum Hemorrhage (PPH) Devices Market- Wearable Injectors Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Extremity Reconstruction Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Automated Radiosynthesis Modules Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220                                                              
United States
Toll Free: +1-800-792-5285                                                            
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com 
Web: https://www.alliedmarketresearch.com  
Follow Us on: LinkedIn Twitter